Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

National Urban League CEO Marc Morial Talks Workforce for Black Americans
13:50

PGA Tour CEO Brian Rolapp Talks End of LIV Golf Tie-Up Talks
13:37

Lyft CEO David Risher Talks Company Expansion
07:40